Triglyceride-Glucose Index Linked to 283 Diseases
A large UK Biobank cohort study links the metabolic marker to elevated risk across a quarter of diseases tested, partly through inflammation.
Updated on Nov. 15, 2026 in Diseases — General

Researchers tested the triglyceride-glucose index against 1,127 diseases among 361,175 UK Biobank participants and found significant associations with 283 of them. Low-grade chronic inflammation accounted for part of the link in 217 of those associations.
Why it matters
The index is a simple blood-based measure of insulin resistance, and its association with a broad range of conditions suggests it may help flag wider health risks. The finding that inflammation explains part of many of these links points to a possible biological pathway that could guide future prevention research.
The analysis covered 361,175 participants with a mean age of 56.5 years and a median follow-up of 13.5 years, with hazard ratios up to 4.61 across the 283 significant associations. Whether the inflammation pathway is the mechanism behind these links remains unconfirmed by this observational design.
The players
UK Biobank
UK Biobank is a large-scale biomedical database and research resource containing genetic, lifestyle and health data from roughly half a million UK participants, widely used for long-term epidemiological studies.
The details
Using Cox proportional hazards models adjusted for multiple covariates and corrected for multiple comparisons, the team examined 1,127 diseases. Mediation analysis then tested how much of each positive association ran through a low-grade chronic inflammation score, which showed significant indirect effects in 217 of the 283 associations.
Timeline
The UK Biobank cohort was followed for a median of 13.5 years, the period over which the disease outcomes were tracked.
Health Landscape
The study uses the UK Biobank, a prospective cohort whose long follow-up allows disease outcomes to be linked to baseline metabolic markers across more than a thousand conditions. Its findings extend the use of routinely measured blood markers as broad indicators of population-level disease risk rather than single-disease predictors.
The index is derived from standard fasting triglyceride and glucose measurements, so readers may ask their clinicians about these routine results. The findings are observational and do not yet change recommended screening or treatment.
The takeaway
Routine blood measures such as the triglyceride-glucose index may carry information about a wide range of health risks, and inflammation appears to be one pathway linking them. Readers should discuss their own metabolic results with a clinician rather than act on these population-level associations alone.
Further reading
Explore more on Diseases — General for related research on chronic conditions and their risk factors.







